Literature DB >> 8091948

Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

K Wakabayashi1, K Oyanagi, T Makifuchi, F Ikuta, A Homma, Y Homma, Y Horikawa, S Tokiguchi.   

Abstract

We have studied brain tissues from three patients with corticobasal degeneration (CBD) histologically, ultrastructurally and immunohistochemically. Ballooned neurons in the cerebral cortex and severe degeneration of the substantia nigra were observed in them all and weakly basophilic neurofibrillary tangles (NFTs) were distributed widely in the basal ganglia and brain stem. Ultrastructural examination demonstrated that the NFTs comprised characteristic 15-nm-wide straight tubules, which showed positive immunohistochemical staining with an antibody against tau, but not ubiquitin. Tau-immunoreactive neuronal cell bodies without NFTs also were found in the cerebral cortex and subcortical nuclei, predominantly in the brain stem, and the greatest number of tau-positive glial inclusions occurred in the cerebral gray and white matter of the pre- and post-central gyri. These inclusions comprised tubular structures with diameters of about 15 nm and were localized in the oligodendroglial cellular cytoplasm and processes. These findings indicate that there is a close cytoskeletal pathological relationship between CBD and progressive supranuclear palsy.

Entities:  

Mesh:

Year:  1994        PMID: 8091948     DOI: 10.1007/bf00293314

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  37 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome.

Authors:  I Tellez-Nagel; H M Wiśniewski
Journal:  Arch Neurol       Date:  1973-11

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Comparative immunohistochemical study on the expression of alpha B crystallin, ubiquitin and stress-response protein 27 in ballooned neurons in various disorders.

Authors:  S Kato; A Hirano; T Umahara; M Kato; F Herz; E Ohama
Journal:  Neuropathol Appl Neurobiol       Date:  1992-08       Impact factor: 8.090

7.  Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei.

Authors:  K Arima; S Murayama; S Oyanagi; T Akashi; T Inose
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

9.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Neurosci Lett       Date:  1992-01-20       Impact factor: 3.046

10.  Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy.

Authors:  M Nishimura; Y Namba; K Ikeda; M Oda
Journal:  Neurosci Lett       Date:  1992-08-31       Impact factor: 3.046

View more
  31 in total

1.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response.

Authors:  David B Wang; Robert D Dayton; Richard M Zweig; Ronald L Klein
Journal:  Exp Neurol       Date:  2010-03-24       Impact factor: 5.330

3.  Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.

Authors:  Ronald L Klein; Robert D Dayton; Nancy J Leidenheimer; Karen Jansen; Todd E Golde; Richard M Zweig
Journal:  Mol Ther       Date:  2005-12-01       Impact factor: 11.454

Review 4.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

Review 5.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

6.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

Review 7.  The new neuropathology of degenerative frontotemporal dementias.

Authors:  M Jackson; J Lowe
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

8.  Discrepancy between clinical and pathological diagnoses of CBD and PSP.

Authors:  Toshiki Mizuno; Kensuke Shiga; Yuriko Nakata; Junko Nagura; Taizen Nakase; Yoshihiro Ueda; Yoshiaki Takanashi; Kohji Urasaki; Yumiko Oyamada; Shinji Fushiki; Junji Nishikawa; Masahiro Yasuhara; Kenji Nakajima; Masanori Nakagawa
Journal:  J Neurol       Date:  2005-03-09       Impact factor: 4.849

9.  Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Cynthia G Diaczynsky; Michael F Salvatore
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

10.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.